Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate ...
MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on finding new therapeutic targets in inflammatory bowel disease (IBD). The ...
How-To Geek on MSN
You’re using the wrong app to open ZIP files on Windows
Don't overcomplicate things for yourself.
Submission supported by data from Phase 3 pivotal AFFIRM study If approved, adult Crohn's disease patients will have an additional option for induction of risankizumab-rzaa ...
Responding to reports from peer reviewers is a crucial part of scientific publishing, but early-career researchers are rarely taught about this process.
Related Digital and funds affiliated with Blackstone have secured the equity and debt financing needed to fund the $16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results